2025 Annual Report
2023 highlighted how important networks are in biology and research, driving progress in biomedicine.
This report explores the interconnectedness that fosters innovation, from cellular systems to the patient, covering ambitious scientific collaborations with top research centres, companies, and hospitals.
[Copiado de 2023]
In 2025, with over 150 publications, IRB Barcelona has advanced our understanding of cancer, ageing, and therapy resistance, uncovering mechanisms that shape disease evolution.
2025 in numbers
150
SCIENTIFIC PUBLICATIONS
29
RESEARCH GROUPS
€41.1M
BUDGET
Research
76%
PUBLICATIONS IN D1 JOURNALS
IRB Barcelona has revealed how cells evolve and adapt in health and disease, from cancer initiation to ageing. Using experimental and computational approaches, we have shown how internal states and the environment shape disease, advancing knowledge for biomedical innovation.
Scientific projects
€24.9M
EXTERNAL FUNDING
IRB Barcelona has secured competitive funding from national and international organizations, including la Caixa, BBVA, AECC, and FERO. These grants are supporting collaborative cancer research on tumour progression, immunotherapy resistance, and rare diseases, among other areas, reinforcing biomedical discovery and impact.
Innovation
6
ACTIVE SPIN-OFFS
IRB Barcelona’s innovation ecosystem has advanced the clinical adoption of the MAF Test for breast cancer, among other achievements. The test refines treatment selection, avoids overtreatment, and improves survival in high-risk patients, thereby strengthening our impact in precision oncology.
The MAF Test®, developed by IRB Barcelona spin-off Inbiomotion, has been adopted by leading public…
Nature has featured IRB Barcelona in a special report on the rise of Barcelona as a European biotech hub,…
Nuage Therapeutics, a spin-off of IRB Barcelona and ICREA co-founded by researchers Dr. Xavier Salvatella,…
People & Talent
511
PROFESSIONALS
IRB Barcelona has reinforced its scientific community through multicentre training programmes with VHIO and EU doctoral initiatives. Researchers have received EMBO Young Investigator recognition and the Rei Jaume I Prize, while global networks and conferences have trained the next generation of biomedical leaders.
Communications & Public Engagement
2,940
Impacts in media
IRB Barcelona’s discoveries have reached society through a variety of channels, including media outlets, social media, and in-person activities. These efforts seek to bring biomedical science into public conversation, strengthen scientific culture, and foster dialogue—reaching both national and international audiences while reinforcing our role as a global voice in life-science research.
6,182
PARTICIPANTS IN IN-PERSON OUTREACH ACTIVITIES
Initiatives such as our annual Open Day and Artist in Residence Programme further promote dialogue with the public and offer hands-on experiences of science and research in the field of biomedicine.
Fundraising
€5.1M
Raised since the launch of the Metastasis Challenge
IRB Barcelona has reached the €5 M milestone of the Metastasis Challenge, allowing us to advance our research. Moreover, this year was exceptional with respect to fundraising as we have raised €1.7 M through strategic collaborations and community initiatives supporting cancer research and biomedical innovation.
Thank you!
Our heartfelt gratitude goes to the scientists, staff, collaborators, and partner institutions whose passion and dedication made 2025 a year of breakthrough achievements.
We are especially thankful to the donors, patients, advocates, and community members who drive the Metastasis Challenge forward—every voice raised, every event organized, and every gesture of support brings us closer to our goal of beating metastasis and transforming lives.